At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TXMD TherapeuticsMD
Closed Christmas Day 12-24 13:00:00 EST
1.11
+0.02
+1.38%
盘后1.11
+0.000.00%
16:23 EST
High1.15
Low1.09
Vol8.54K
Open1.09
D1 Closing1.10
Amplitude5.43%
Mkt Cap12.80M
Tradable Cap10.31M
Total Shares11.53M
T/O9.51K
T/O Rate0.09%
Tradable Shares9.29M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.